Keep the purchased function clear
PAC is polyaluminum chloride in this treatment context; the proposed polymer flocculant is a separate material. State whether the objective is improved settling, stronger floc, less carryover or another measurable result after the existing coagulation step.
The coagulant and flocculant distinction prevents an ambiguous order. Do not request replacement of both chemicals when the immediate purchasing question concerns a polymer aid for the accepted PAC program.
Preserve the coagulant baseline
Record PAC identity, concentration basis, actual dose, final pH, correction and contact time. Keep these controlled while screening the polymer unless the experiment deliberately evaluates a complete program change.
An apparently improved polymer result may reflect a changed coagulation condition. Include coagulant-only and current-program controls so the role of the candidate aid remains interpretable.
Specify the polymer sample panel
Ask for a small explained panel across suitable ionic and molecular profiles and supplied forms. The coagulant's presence does not automatically establish that one charge family is always correct.
Link each code to the grade and active definition. Compare candidates in representative PAC-treated water rather than select a polymer solely from a general compatibility statement or a supplier's unrelated demonstration.
Match the addition and mixing route
Map where coagulant disperses, where polymer enters and how much contact is available before separation. Use grade-specific preparation and the operator's approved dilute testing procedure. Do not improvise concentrated-product blending.
Record transfer shear and any mixing changes needed for the candidate. A promising jar made with an unavailable sequence is not a practical qualification for the installed treatment train.
Measure a useful two-chemical window
Use a controlled matrix around feasible coagulant and polymer conditions. Keep both dose bases explicit and record final pH, clarified water, settling or flotation and relevant sludge or filter behaviour.
Do not select a fixed PAC-to-polymer ratio as a universal recipe. Repeat decisive points and challenge normal and difficult water conditions so a narrow attractive combination is not mistaken for robust operating control.
Compare the whole accepted program
Price the polymer at its demonstrated consumption and include any proven change in coagulant, correction, preparation or solids handling. If PAC conditions remain fixed, report that explicitly rather than claim savings in an unchanged component.
Use the accepted-water cost method and retain the original baseline. A low polymer price or a larger floc does not independently establish lower total treatment cost.
Release both identities and the sequence
Record PAC and polymer codes, accepted water envelope, preparation, addition points, doses and measurements. Define which coagulant or polymer changes require review and who owns the technical decision.
Send the current PAC program, separator, water data and sample requirements through the polymer coagulant-aid enquiry. Request a bounded aid proposal, not an unsupported promise of compatibility with every PAC formulation.
Retain a two-chemical acceptance sheet
Give PAC and polymer separate fields for code, dose basis, actual addition, preparation and documentary status. Add the tested sequence, final pH and separator result. State whether the comparison held PAC fixed or deliberately changed the complete program.
This sheet lets purchasing compare the component actually being bought without losing the accepted chemical context. If either grade changes later, identify which tests must be repeated and which evidence remains relevant, rather than assume a familiar PAC-to-polymer ratio preserves treatment in every water.